Sunshine Biopharma Announces Canadian Subsidiary Nora Pharma Acquired Two Gastrointestinal Drugs; Launches Prucalopride For Chronic Constipation, Second Drug Launch Planned in 9 Months. Gastrointestinal Market Worth In Excess Of C$200M Per Year.

BenzingaMar 10 09:08 ET

Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market

AccesswireMar 10 09:00 ET

Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT

AccesswireJan 21 08:02 ET

Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer

AccesswireJan 15 08:00 ET

Sunshine Biopharma Files For Offering Of Mixed Shelf Of Up To $100M

BenzingaJan 6 11:56 ET

Express News | Sunshine Biopharma Announces Development Of An Orally Active Protease Inhibitor With Dose-Dependent Antiviral Activity In Mice With SARS-CoV-2)

BenzingaDec 9, 2024 07:36 ET